Literature DB >> 27862018

What is wrong with 'being a pill-taker'? The special case of statins.

Louisa Polak1.   

Abstract

In an interview study of decision-making about statins, many participants said they took pills regularly, yet described themselves as 'not really pill-takers'. This paper explores this paradox and its implications. The practice of pill-taking itself can constitute a challenge to the presentation of moral adequacy, beyond the potential for rendering stigmatised illnesses visible. Meeting this challenge involves a complex process of calibrating often-conflicting moral imperatives: to be concerned, but not too concerned, over one's health; to be informed, but not over-informed; and deferential but not over-deferential to medical expertise. This calibration reflects a broader tension between rival tropes: embracing medical progress and resisting medicalisation. Participants who take statins present them as unquestionably necessary; 'needing' pills, as opposed to choosing to take them, serves as a defence against the devalued identity of being a pill-taker. However, needing to take statins offers an additional threat to identity, because taking statins is widely perceived to be an alternative strategy to 'choosing a healthy lifestyle'. This perception underpins a responsibilising health promotion discourse that shapes and complicates the work participants do to avoid presenting themselves as 'pill-takers'. The salience of this discourse should be acknowledged where discussions of medicalisation use statins as an example.
© 2016 Foundation for the Sociology of Health & Illness.

Entities:  

Keywords:  adherence; cardiovascular disease; healthism; identity; medicalisation; surveillance medicine

Mesh:

Substances:

Year:  2016        PMID: 27862018     DOI: 10.1111/1467-9566.12509

Source DB:  PubMed          Journal:  Sociol Health Illn        ISSN: 0141-9889


  7 in total

1.  Experiences of Patients Taking Conditioned Open-Label Placebos for Reduction of Postoperative Pain and Opioid Exposure After Spine Surgery.

Authors:  Valerie Hruschak; K Mikayla Flowers; Megan Patton; Victoria Merchantz; Emily Schwartz; Robert Edwards; Ted Kaptchuk; James Kang; Michelle Dossett; Kristin Schreiber
Journal:  Int J Behav Med       Date:  2022-08-01

2.  Engagement with advice to reduce cardiovascular risk following a health check programme: A qualitative study.

Authors:  Samah Alageel; Martin C Gulliford; Alison Wright; Bernadette Khoshaba; Caroline Burgess
Journal:  Health Expect       Date:  2019-10-23       Impact factor: 3.377

3.  Information or Habit: What Health Policy Makers Should Know about the Drivers of Self-Medication among Romanians.

Authors:  Elena Druică; Cristian Băicuș; Rodica Ianole-Călin; Ronald Fischer
Journal:  Int J Environ Res Public Health       Date:  2021-01-14       Impact factor: 3.390

4.  Dealing with being prescribed cardiovascular preventive medication: a narrative analysis of qualitative interviews with patients with recent acute coronary heart disease in Sweden.

Authors:  Josabeth Hultberg; Staffan Nilsson; Carl Edvard Rudebeck; Anita Kärner Köhler
Journal:  BMJ Open       Date:  2021-12-17       Impact factor: 2.692

5.  The Disparate Approaches of General Practitioners to the Pharmaceuticalisation of Cardiovascular Disease Prevention.

Authors:  Tom Douglass; Michael Calnan
Journal:  Front Sociol       Date:  2021-05-21

6.  Adherence and the Moral Construction of the Self: A Narrative Analysis of Anticoagulant Medication.

Authors:  Meredith K D Hawking; John Robson; Stephanie J C Taylor; Deborah Swinglehurst
Journal:  Qual Health Res       Date:  2020-08-28

7.  Person-centred care in practice: perspectives from a short course regimen for multi-drug resistant tuberculosis in Karakalpakstan, Uzbekistan.

Authors:  Shona Horter; Beverley Stringer; Nell Gray; Nargiza Parpieva; Khasan Safaev; Zinaida Tigay; Jatinder Singh; Jay Achar
Journal:  BMC Infect Dis       Date:  2020-09-16       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.